Ortiz-de TA, Barrios-Moyano A, González-Perales A, Gerbacio-Blando L

Language: Spanish
References: 11
Page: 36-43
PDF size: 207.20 Kb.

ABSTRACT

Introduction: gonarthrosis is a degenerative disease, whose loss of cartilage causes changes in the adjacent bone and its response produces deformations and attempts at regeneration. In 1934 Meyer and Palmer isolated bovine vitreous humor, a polysaccharide called hyaluronic acid, which has the property of visco-elasticity. Today, multiple procedures performed in orthopedics are known, in order to limit the degenerative process that this entails. Objective: to know the use and efficacy of hyaluronic acid in the patient requiring knee arthroscopy, evaluating the evolution of the patient using the WOMAC scale; as well as the ideal time of application of hyaluronic acid in this study group. Material and methods: clinical, non-randomized, prospective, analytical trial. 48 patients from 45 to 60 years of age, divided into 3 groups with a diagnosis of gonarthrosis grade II-III, who underwent arthroscopy with subsequent hyaluronic acid application, were evaluated; in the postoperative period (group 1), one month after the postoperative period (group 2) and without application (group 3) in a period from September 2015 to June 2016 at the ISSSTE Hospital "Dr. Darío Fernández Fierro". Results: the treatment showed differences in patients regarding reduction of pain and stiffness; and improvement in functional capacity. Conclusion: despite, there are no conclusive results if the treatment is better than the other, certain data suggests that using hyaluronic acid in the postoperative improves rigidity and function, however, it was not statistically significant.

REFERENCES

1. López-Armada MJ, Carames B, Cillero-Pastor B, Blanco GFJ. Fisiopatología de la artrosis: ¿cuál es la actualidad? Rev Esp Reumatol. 2004; 31(6): 379-93.

2. Toquero TJF, Zarco RJ, Pedro CG, Lobos BM, Palomo SV. Guía de buena práctica clínica en prevención del riesgo cardiovascular. 2007, pp. 3-88.

3. Cortés BJ, García SP, García MA, Polche V, Selva OJ. Viscosupplementation: review of hyaluronic acids in Spain. Farm Hosp. 2000; 24(6): 371-376.

4. Huskin JP, Vandekerckhove B, Delince P, et al. Multicentre, prospective, open study to evaluate the safety and efficacy of hylan G-F 20 in knee osteoarthritis subjects presenting with pain following arthroscopic meniscectomy. Knee Surg Sports Traumatol Arthrosc. 2008; 6(8): 747-52.

5. Ayral X. Arthroscopy and joint lavage. Best Pract Res Clin Rheumatol. 2005. 19 (3): 401-15.

6. Sánchez-Naranjo JC, López-Zapata DF. Fisiopatología celular de la osteoartritis: el condrocito articular como protagonista. Iatreia. 2011; 24(2): 167-78.

7. Insall, and Scott WN. Cirugía de rodilla, 4ª ed. Editorial Elsevier; Tomo 2; 2006, pp. 1089-1101-49.

8. Landínez-Parra NS, Vanegas-Acosta JC, Garzón-Alvarado DA. Regulación molecular del cartílago articular en función de las cargas mecánicas y el proceso osteoartrósico. Rev Cub Ortop Traumatol. 2008; 22(2).

9. Legré-Boyer V. Viscosupplementation: techniques, indications, results. Orthop Traumatol Surg Res. 2015; 101(1 Suppl): S101-8.

10. Castellet FE, Vidal N, Conesa X. Escalas de valoración en cirugía ortopédica y traumatología. Ed Fundación Mapfre Trauma. 2010; 21(1): 33-43.

11. Waddell DD, Bert JM. The use of hyaluronan after arthroscopic surgery of the knee. Arthroscopy. 2010; 26(1): 105-11.

EVIDENCE LEVEL

II